Covalently closed nucleic acid molecules for immunostimulation

Details Covalently closed nucleic acid molecules for immunostimulation Covalently closed nucleic acid molecules for immunostimulation

2005-02-01

2005-02-01

LeGuyader, John L. (Department: 1635)

Organic compounds -- part of the class 532-570 series

Organic compounds

Carbohydrates or derivatives

Reexamination Certificate

active

06849725

ABSTRACT:
Short deoxyribonucleic acid molecules that are partially single-stranded, dumbbell-shaped, and covalently closed, which contain one or more unmethylated cytosine guanosine motif (CpG motif) and exhibit immunomodifying effects. Such molecules can be used for immunostimulation applications in humans or vertebrates.

REFERENCES:
patent: 5663153 (1997-09-01), Hutcherson et al.
patent: 5723335 (1998-03-01), Hutcherson et al.
patent: 5750669 (1998-05-01), Rösch et al.
patent: 5856462 (1999-01-01), Agrawal
patent: 0855184 (1998-07-01), None
patent: 2732971 (1996-10-01), None
patent: 9818810 (1998-05-01), None
patent: 9821322 (1998-05-01), None
Krieg et al. Immunology Today, vol. 21, No. 10, pp. 521-526 (2000).*
Weiner, G. J. Leukocyte Biol. vol. 68, pp. 455-463 (2000).*
Agrawal et al. Molecular Med. Today, vol. 6, pp. 72-81 (2000).*
McCluskie et al. Molecular Med. vol. 5, No. 5, pp. 287-300 (1999).*
Erie, D. et al. Biochemistry, vol. 26, No. 22, pp. 7150-7159 (1987).*
Wolters, M. et al. Nucleic Acids Res., vol. 17, No. 13, pp. 5163-5172 (1989).*
Kreig AM, Yi AK, Matson S. Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, Klinmän DM;(CpG motifs in bacterial DNA trigger direct B-cell activation; Nature Apr. 6, 1995 374;6522 546-9.
Seder RA and Paul WE, Acquisition of lymphokine-producing phenotype by CD4+ T cells; Annu Rev Immunol. 1994;12:635-73.
Melief CJ, Kast WM; T cell immunotherapy of cancer; Res Immunol Jun. Aug. 1991;142(5-6);425-9.
Pasternak G, Hochhaus A, Schultheis B, Hehlmann R; Chronic myelogeneous leukemia: molecular and cellular aspects: J Cancer Res Clin Oncol 1998;124(12):643-60.
Weber LW, Bowne WB, Wolchok JD, Srinivasan R, Qin J, Moroi Y, Clynes R, Song P, Lewis JJ, Houghton AN; Tumor immunity and autoimmunity induced by immunization with homologous DNA; J Clin Invest Sep. 15, 1998;102(6):1258-64.
Surman DR, Irvine KR, Shulman EP, Allweis TM, Rosenberg SA, Restifo NJ; Generation of polyclonal rabbit antisera to mouse melanoma associated antigens using gene gun immunization; Immunal Methods; May 1, 1998;214(1-2):51-62.
Kovarik J, et al. CpG oligodeoxynucleotides can circumvent the Th2 polarization of neonatal responses to vaccines but may fail to fully redirect Th2 responses established by neonatal priming; J Immunol. Feb. 1, 1999;162(3):1611-7.
Krieg AM, Wu T, Weeratna R, Efler SM, Love-Homan L, Yang L, Yi Ak, Short D, Davis HL; Sequence motifs in adenoviral DNA block immune activation by stimulatory CpG motifs; Proc Natl Acad Sci U S A Oct. 13, 1998;95(21):12631-6.
Kreig AM, CpG DNA: a pathogenic factor in systemic lupus erythematosus?, J Clin Immunol Nov. 1995;15(6) :204-92.
Sheehan and Lan, Phosphorothioate Oligonucleotides Inhibit the Intrinsic Tanase Complex, Blood 92, 1617-1625(1998).
Lim et al., Sequence-independent inhibiton of RNA transcription by DNA dumbbells and other decoys, 1997, Nuc. Acids Res. 25, 575-581; Blumenfeld et al., Nuc. Acids Res. 1993, 21, 3405-3411.
Weeratna R, Brazolot Millan CL, Krieg AM, Davis HL; Reduction of antigen expression from DNA vaccines by coadministered oligodeoxynucleotides. Antisense Nucleic Acid Drug Dev Aug. 1998;8(4):351-6.
Immunostimulatory oligodeoxynucleotides promote protective immunity and provide systemic therapy for leishmaniasis via IL-12- and IFN-gamma-dependent mechanisms, Walker et al., Proc Natl Acad Sci USA Jun. 8, 1999 96:12 6970-5.
Clusel C et al: “Ex Vivo Regulation of Specific Gene Expression by Hanomolar Concentration of Double-Stranded Dumbell Oligonucleotides” Nucleic Acids Research,GB,Oxford University Press, Surrey, vol. 21, No. 15, Jul. 25, 1993, pp. 3405-3411, XP000572382 ISSN: 0305-1048 the whole document.
Krieg A M et al: “Oligodeoxyncleotide Modifications Determine the Magnitude of B Cell Stimulation by CPG Motifs” Antisense & Nucleic Acid Drug Development, US,Mary Ann Liebert, Inc., New York, vol. 6, No. 2, 1996, pp:133-139, XP000610233 ISSN: 1087-2906 the whole document.
Erie D et al: “A Dumbell-Shaped Double-Hairpin Structure of DNA: A Thermodynamicinvestigation” Biochemistry 1987, XP002027687 the whole document.
Hosona et al, Properties of Base-Pairing in the Stem Region of Hairpin Antisense Oligonucleotides Containing 2′-Methcxynucleosides, Biochim Biophys, Acta 244, 339-344 (1995).

Affiliated with

Also associated with

Rating

Covalently closed nucleic acid molecules for immunostimulation does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Covalently closed nucleic acid molecules for immunostimulation, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Covalently closed nucleic acid molecules for immunostimulation will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3452661